O’Melveny represented China International Capital Corporation Hong Kong Securities Limited as the sole sponsor and overall coordinator in the IPO. Qyuns Therapeutics Co., Ltd. (2509.HK) announced...
You must be a Standard 1 Year member to access this content.
O’Melveny represented the sole sponsor, the coordinators and the underwriters in the transaction. Beijing Fourth Paradigm Technology Co., Ltd. (6682.HK) announced its initial public offering and listing...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised the joint sponsors on the deal while O’Melveny represented Sipai Health Technology Co., Ltd, Eight Roads and F-Prime. The joint sponsors Morgan Stanley...
You must be a Standard 1 Year member to access this content.
